AMGN
AMGEN INCCompliant · 78/100
Sector: Healthcare · Industry: Biotechnology · Data as of 2026-02-13
Screening standard
The evidence
| Test | Figure | Limit | Source |
|---|---|---|---|
| Passed: Business activityBusiness activity is compliant. | compliant | ||
| Passed: Debt vs. market capinterest-bearing debt / market cap = 31.58% (< 33% limit). | 31.58% | < 33.00% | |
| Passed: Interest income vs. revenueinterest income / total revenue = 1.11% (< 5% limit). | 1.11% | < 5.00% | |
| Passed: Cash & interest-bearing assets vs. market cap(cash + interest-bearing securities) / market cap = 5.28% (< 33% limit). | 5.28% | < 33.00% |
Every number, sourced
Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.
| Figure | Value | Source |
|---|---|---|
| Total revenueRevenue from contract with customer excluding assessed tax | $36.8B | |
| Interest-bearing debtLong term debt | $54.6B | |
| Cash & interest-bearing securitiesCash and cash equivalents at carrying value | $9.1B | |
| Interest incomeInvestment income interest | $408.0M | |
| Total assetsAssets | $90.6B | |
| ReceivablesAccounts receivable net current | $9.6B | |
| Shares outstandingEntity common stock shares outstanding | 539.7M shares | |
| Priceyahoo:24mo-trailing-avg | $320.323 |
Price
Values & Controversies
Separate from the shariah verdict above — always.
No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we line.